Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Big pharma-backed AdvanCell pockets $315m to progress RLT to Phase III | PharmaVoice

Pharma Tech

Big pharma-backed AdvanCell pockets $315m to progress RLT to Phase III

Jul 16, 2026, 9:56 AM

Read Full Article → Big pharma-backed AdvanCell pockets $315m to progress RLT to Phase III

Big pharma-backed AdvanCell pockets $315m to progress RLT to Phase III

Translate article text

Choose a language and wait for the translated text.

AdvanCell will use the mega-round earnings to progress ADVC001 and build radiopharmaceutical manufacturing infrastructure.